Biomedical
11 Sep 2018
Kidney cancer news
26 Sep 2023
Coalition for reducing bureaucracy in clinical trials
20 Sep 2023
Tips for staying strong with advanced kidney cancer
11 Sep 2023
Anticancer medication and risk of blood clots in hospitalised cancer patients with COVID-19
4 Sep 2023
Steve Pointon: Supporting people with person-centred counselling
21 Aug 2023
Leicester NHS Trust receives funding for robotic surgery theatre
21 Aug 2023
Belzutifan significantly delays progression of advanced kidney cancer after other treatments have failed
15 Aug 2023
Corticosteroids during treatment with nivolumab may not affect survival in kidney cancer
15 Aug 2023
How long side effects last after treatment with axitinib is stopped
26 Jul 2023
2022 National Cancer Patient Experience Survey
25 Jul 2023
Partial nephrectomy versus ablation for early stage kidney cancer in the elderly
19 Jul 2023
Early cancer detection test using ctDNA
19 Jul 2023
WECAN Academy 2023
Most used tags
renal cell carcinoma immunotherapy combination therapy checkpoint inhibitors Cancer nivolumab TKIs overall survival Opdivo sunitinib Sutent cabozantinib progression-free survival NHS England biomarkers ipilimumab Cabometyx pembrolizumab COVID-19 cancer survival axitinib VEGF inhibitors non-clear cell kidney cancer Inlyta coronavirus Yervoy risk factors Keytruda metastases adjuvant therapy biological markers targeted therapy papillary RCC everolimus Afinitor cancer outcomes ASCO first-line treatment partial nephrectomy NICEArchives
- 2023: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2022: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2021: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2020: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2019: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2018: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2017: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
- 2016: Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
